lobbying_activities: 2969641

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2969641	d06c502c-14a7-47cc-a8d4-af5560b52f70	Q1	CROSSROADS STRATEGIES, LLC	400531586	INDIVIOR INC.	2023	first_quarter	PHA	Issues related to overdose reversal products; H.R.2617, Consolidated Appropriations Act, 2023 (P.L.117-328) implementation; FY2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2023-04-19T13:46:11-04:00